FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY

Clinical trials for FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY explained in plain language.

Never miss a new study

Get alerted when new FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY trials appear

Sign up with your email to follow new studies for FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug candidate GL-0719 enters first human safety trials for rare blood disorder

Disease control Recruiting now

This early-stage study tests a new drug called GL-0719 for the first time in humans. It aims to check the drug's safety and how the body processes it in healthy adults and in people with cold agglutinin disease, a rare condition where the immune system attacks red blood cells in …

Matched conditions: FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY

Phase: PHASE1 • Sponsor: Gliknik Inc. • Aim: Disease control

Last updated May 01, 2026 15:59 UTC

FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY

Get alerted when new FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY trials appear

New drug candidate GL-0719 enters first human safety trials for rare blood disorder